← Leaderboards
Emily C Walvoord
Indiana Univ-Purdue Univ At Indianapolis
$48,595
Attributed
$48,595
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.1K · FY2006–08$5K$3.8K$2.5K$1.3K$0
'06
'07
'08
Funding mix
By agency
NIH$48,595 · 4
By mechanism
F32$42,628 · 1
M01$5,967 · 3
Top collaborators
No co-investigators on record.
Most similar at Indiana Univ-Purdue Univ At Indianapolis
Same institution · by research overlap
- Tamara S Hannon$4,645,857
- Robert M Bigsby$1,705,117
- Simon James Rhodes$2,606,399
Others in their field
Top investigators on “Somatotropin”
- Brian E Henderson · University Of Southern California$17,806,295
- Johannes D Veldhuis · University Of Virginia Charlottesville$14,094,397
- Dan M Cooper · University Of California San Diego$13,278,892
- Stanley B Prusiner · University Of California San Francisco$12,108,025
- Steven Kyle Grinspoon · Massachusetts General Hospital$11,432,307
- David J Waxman · Boston University Medical Campus$10,042,015
Research focus
SomatotropinInflammatoryEnd PointBone DensityCellsAffectAttentionAdverse EffectsConditionCrohn&AposDailyDietDouble-Blind MethodChronicHormone AnalogClinical TrialsEtiologyComputer Retrieval Of Information On Scientific Projects DatabaseFundingGastrointestinal Tract StructureGerefGrantGrowthIndexing
Grant awards (4)
RX OF CROHN'S DISEASE W/GROWTH HORMONE RELEASING HORMONE VS PLACEBO$262
M01 · FY2008 · RR · contact PI
RX OF CROHN'S DISEASE W/GROWTH HORMONE RELEASING HORMONE VS PLACEBO$3,079
M01 · FY2007 · RR · contact PI
A PHASE 1B MULTIPLE DOSE SAFETY, PHARMAKOKINETIC(PK) ANDPHARMACODYNAMIC(PD)$2,626
M01 · FY2006 · RR · contact PI
CNS FUNCTION OF GHRH RELATED PEPTIDE$42,628
F32 · FY2000 · DK